These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33973676)

  • 1. Commentary on Donoghue: Low prescribing rates of pharmacotherapy for alcohol use disorder limit potential public health impact.
    Morley KC
    Addiction; 2021 Nov; 116(11):3027-3028. PubMed ID: 33973676
    [No Abstract]   [Full Text] [Related]  

  • 2. Implementing alcohol use disorder pharmacotherapy in primary care settings: a qualitative analysis of provider-identified barriers and impact on implementation outcomes.
    Hagedorn HJ; Wisdom JP; Gerould H; Pinsker E; Brown R; Dawes M; Dieperink E; Myrick DH; Oliva EM; Wagner TH; Harris AHS
    Addict Sci Clin Pract; 2019 Jul; 14(1):24. PubMed ID: 31291996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of alcohol use disorder pharmacotherapy receipt in medically insured patients.
    Rittenberg A; Hines AL; Alvanzo AAH; Chander G
    Drug Alcohol Depend; 2020 Sep; 214():108174. PubMed ID: 32721788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of alcohol pharmacotherapies on public health in Australia is limited by low prescribing rates.
    Haber PS; Morley KC
    Public Health Res Pract; 2016 Sep; 26(4):. PubMed ID: 27714386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy for alcohol addiction in a patient with alcoholic cirrhosis and massive upper gastrointestinal bleed: A case study.
    Young S; Wood E; Ahamad K
    Drug Alcohol Rev; 2016 Mar; 35(2):236-9. PubMed ID: 26094844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers to and facilitators of pharmacotherapy for alcohol use disorder in VA residential treatment programs.
    Finlay AK; Ellerbe LS; Wong JJ; Timko C; Rubinsky AD; Gupta S; Bowe TR; Burden JL; Harris AHS
    J Subst Abuse Treat; 2017 Jun; 77():38-43. PubMed ID: 28476269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers.
    Harris AHS; Ellerbe L; Reeder RN; Bowe T; Gordon AJ; Hagedorn H; Oliva E; Lembke A; Kivlahan D; Trafton JA
    Psychol Serv; 2013 Nov; 10(4):410-419. PubMed ID: 23356858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy of alcohol dependence: past, present and future research.
    Leggio L; Addolorato G
    Curr Pharm Des; 2010; 16(19):2074-5. PubMed ID: 20482504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of a clinical pharmacy specialist into a substance use disorder intensive outpatient treatment program to improve prescribing rates of alcohol use disorder pharmacotherapy.
    Dimitropoulos E; Bertucci S; Wong K
    Subst Abus; 2018; 39(2):190-192. PubMed ID: 29558338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research opportunities for medications to treat alcohol dependence: addressing stakeholders' needs.
    Litten RZ; Falk D; Ryan M; Fertig J
    Alcohol Clin Exp Res; 2014 Jan; 38(1):27-32. PubMed ID: 23889161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of tailored, postal feedback on general practitioners' prescribing of pharmacotherapies for alcohol dependence.
    Navarro HJ; Shakeshaft A; Doran CM; Petrie DJ
    Drug Alcohol Depend; 2012 Aug; 124(3):207-15. PubMed ID: 22361211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy of alcohol dependence.
    Zernig G; Fabisch K; Fabisch H
    Trends Pharmacol Sci; 1997 Jul; 18(7):229-31. PubMed ID: 9253852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparities in pharmacotherapy for alcohol use disorder in the context of universal health care: a Swedish register study.
    Karriker-Jaffe KJ; Ji J; Sundquist J; Kendler KS; Sundquist K
    Addiction; 2017 Aug; 112(8):1386-1394. PubMed ID: 28406579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to and Facilitators of Alcohol Use Disorder Pharmacotherapy in Primary Care: A Qualitative Study in Five VA Clinics.
    Williams EC; Achtmeyer CE; Young JP; Berger D; Curran G; Bradley KA; Richards J; Siegel MB; Ludman EJ; Lapham GT; Forehand M; Harris AHS
    J Gen Intern Med; 2018 Mar; 33(3):258-267. PubMed ID: 29086341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapies and personalized medicine for alcohol use disorder: a review.
    Lohoff FW
    Pharmacogenomics; 2020 Oct; 21(15):1117-1138. PubMed ID: 32807012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the pharmacotherapy of alcoholism.
    Myrick H; Anton R
    Curr Psychiatry Rep; 2004 Oct; 6(5):332-8. PubMed ID: 15355755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining psychosocial treatment with pharmacotherapy for alcohol dependence.
    Weiss RD; Kueppenbender KD
    J Clin Psychopharmacol; 2006 Dec; 26 Suppl 1():S37-42. PubMed ID: 17114954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy for Alcohol Dependence: The 2015 Recommendations of the French Alcohol Society, Issued in Partnership with the European Federation of Addiction Societies.
    Rolland B; Paille F; Gillet C; Rigaud A; Moirand R; Dano C; Dematteis M; Mann K; Aubin HJ
    CNS Neurosci Ther; 2016 Jan; 22(1):25-37. PubMed ID: 26768685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rational approach to the pharmacotherapy of alcohol dependence.
    Petrakis IL
    J Clin Psychopharmacol; 2006 Dec; 26 Suppl 1():S3-12. PubMed ID: 17114952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating readiness and treatment seeking effects in a pharmacotherapy trial for alcohol dependence.
    Penberthy JK; Ait-Daoud N; Breton M; Kovatchev B; DiClemente CC; Johnson BA
    Alcohol Clin Exp Res; 2007 Sep; 31(9):1538-44. PubMed ID: 17624996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.